logo-loader
Lexaria Bioscience Corp

Lexaria Bioscience springs for digital marketing services from the Richmond Club

The company will help Lexaria with investor presentations, articles and videos, and other digital marketing services

Contract form
Lexaria Bioscience is a Kelowna, British Columbia company with 40 patents pending around the world for disruptive drug delivery technologies

Lexaria Bioscience Corp (OTCMKTS:LXRP) (CSE:LXX), a drug delivery platform company, has decided to invest in media services for at least the next six months..

Streetwise Investors Club Inc, a Toronto-based company doing business under the name the Richmond Club, will help Lexaria with investor presentations, articles and videos, and other digital marketing services.

READ: Lexaria Bioscience shareholders approve the appointment of four directors

The deal will pay Richmond Club C$3,500 per month for a minimum of six months and will automatically be renewed unless terminated.

Lexaria Bioscience is a Kelowna, British Columbia company with 40 patents pending around the world for disruptive drug delivery technologies. A patent for DehydraTECH, which improves the taste, smell, speed and absorption of compounds, has been granted in the US and Australia.

Its shares slid 3.5% to C$1.09 on the CSE and 3.5% to US$0.84 on OTC Markets on Friday.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: Lexaria Bioscience Corp

Price: $0.89

Market: CSE
Market Cap: $69.99 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp named herein, including the promotion by the Company of Lexaria Bioscience Corp in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Lexaria Bioscience ChrgD up about CBD product launch in the U.S.

Lexaria BioScience (CSE: LXX-OTCQX-LXRP) CEO Chris Bunka joined Steve Darling from Proactive Canada to discuss the company launching a new product featuring hemp oil in a powdered format.  Bunka talks about ChrgD and why this product can demonstrate Lexaria's ability to deliver CBD into...

on 08/22/2019

2 min read